QQ客服 官方微博 反馈留言

	Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D-3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal
	Liao, Er-Yuan; Zhang, Zhen-Lin; Xia, Wei-Bo; Lin, Hua; Cheng, Qun; Wang, Li; Hao, Yong-Qiang; Chen, De-Cai; Tang, Hai; Peng, Yong-De
刊名	BMC MUSCULOSKELETAL DISORDERS
	2018
卷号	19
关键词	Postmenopausal osteoporosis Alendronate sodium Calcitriol Calcifediol Calcium/phosphate metabolism
ISSN号	1471-2474
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609094
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liao, Er-Yuan,Zhang, Zhen-Lin,Xia, Wei-Bo,et al. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D-3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal[J]. BMC MUSCULOSKELETAL DISORDERS,2018,19.
APA	Liao, Er-Yuan.,Zhang, Zhen-Lin.,Xia, Wei-Bo.,Lin, Hua.,Cheng, Qun.,...&Zhang, Lei.(2018).Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D-3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal.BMC MUSCULOSKELETAL DISORDERS,19.
MLA	Liao, Er-Yuan,et al."Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D-3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal".BMC MUSCULOSKELETAL DISORDERS 19(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。